No abstract

ohs micrographic surgery (MMS) is considered a standard of care treatment modality for nonmelanoma skin cancer (NMSC) of the head and neck. However, access to dermatologic care and MMS may be limited by wait times, cost, and the relative shortage of dermatologists in rural areas. 1 Insurance type is associated with increased stage at presentation, differences in treatment, and delays in care for patients with melanoma 2-4 and other noncutaneous cancers, including lung, prostate, breast, and colon cancer. [5][6][7][8][9][10] The objective of this study was to assess whether tumor and treatment characteristics differ based on insurance type among patients undergoing MMS for NMSC because there has been little research investigating this association.

No abstract

No abstract

No abstract